The Mexican pain management drugs market is expected to grow at a CAGR of 2.45% from 2025 to 2030.
The growing middle-class population is correspondingly leading to a rise in the prevalence of lifestyle-related chronic diseases in the country. According to the Oncology Department of Mexico’s National Institute of Cancer (INCAN), 7 out of 10 adults are overweight, one of the leading risk factors for most types of cancer, including breast cancer, prostate cancer, and colon cancer.
Moreover, the rising prevalence of type 2 diabetes is further expanding the population base suffering from joint pain and back pain. According to the World Health Organization (WHO), the country accounts for the most hospitalizations related to diabetes among the Organization for Economic Co-operation and Development’s (OECD) 35 countries. The above factors are bolstering the demand for various pain management drugs to treat different causes of pain. Additionally, the escalating number of surgical procedures performed in Mexican hospitals is also driving the growth of pain management drugs in the country.
Another major driver of the Mexican pain management drugs market is the growing medical tourism industry in the country, supported by the OTC (over-the-counter) availability of cheaper prescription drugs. Rising healthcare costs and wait times in the U.S. and Canada are encouraging people to turn to Mexico to purchase cheaper drugs and medicines.
According to the U.S. government estimates, nearly 1 million people in California alone visit Mexico annually for health care services, including to buy prescription drugs. The presence of larger independent pharmacy chains and discount drug stores in Mexico, as well as rising sales of OTC drugs through the non-pharmacy sector, is attracting several U.S. companies to set up joint development deals with Mexican retailers to boost the sales of OTC drugs, thus positively impacting the pain management drugs market growth. This includes the venture between K-Mart and the Mexican retailer and departmental store company, El Puerto de Liverpool, Price Co’s discount warehouse agreement with Comercial Mexicana, and Wal-Mart’s price-club developments with Mexico’s largest retailer, Cifra.
Mexico Pain Management Drug Market Segmentation